Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
950130 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840090003
- LEI:
- Country:
- United States of America
- Address:
- 65 Clyde Road Suite A, Somerset NJ
- Website:
- https://accessbio.net/
- Sector:
- Manufacturing
Description
Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-05-11 00:00 |
[기재정정]기타경영사항(자율공시)(제19기 임시주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고 )
|
Korean | 8.1 KB | ||
| 2020-04-24 00:00 |
사업보고서 (2019.12)
|
Korean | 1.4 MB | ||
| 2020-04-24 00:00 |
기타경영사항(자율공시)(제18기 임시주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고 )
|
Korean | 4.6 KB |
Automate Your Workflow. Get a real-time feed of all Access Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Access Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Access Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||